Submit Content
Get the latest delivered to your inbox
Privacy Policy

Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

    Living With Metastatic Bladder Cancer: Joey's Journey Image

    POSTED 

    21 hours ago

    Living With Metastatic Bladder Cancer: Joey's Journey

    Watch Joey's story about living with Metastatic Bladder Cancer and his determination to beat it.
    Gilead Sciences Presents at ECCMID 2022 -  Continues Mission to Advance Access to Effective Therapies Image

    POSTED 

    05-12-22

    Gilead Sciences Presents at ECCMID 2022 - Continues Mission to Advance Access to Effective Therapies

    The data we presented at ECCMID 2022 is part of Gilead’s mission to advance access to effective therapies.
    Closing the Representation Gap in Schools, One Black Male Teacher at a Time Image

    POSTED 

    05-09-22

    Closing the Representation Gap in Schools, One Black Male Teacher at a Time

    The deficit of Black male teachers in the United States is profound. According to the U.S. Department of Education, Black men comprise just 2% of all teachers. The Man the Bay fellowship offers a multi-pronged solution.
    Opinion: The Road to Ending Visceral Leishmaniasis Image

    POSTED 

    05-04-22

    Opinion: The Road to Ending Visceral Leishmaniasis

    If left untreated, VL kills 95% of its victims. Though progress has been made, we still have a way to go and, as we look to the next decade, eliminating VL will continue to be a priority for Gilead Sciences.
    On Earth Day, Gilead Marks Strides in Environmental Sustainability Image

    POSTED 

    05-02-22

    On Earth Day, Gilead Marks Strides in Environmental Sustainability

    This Earth Day, we’re highlighting our longstanding commitment to environmental stewardship. We’ll continue to accelerate our efforts to reduce greenhouse gas emissions, minimize waste generation and operate responsibly.
    Gilead Sciences Announces Support for the Robert A. Winn Diversity in Clinical Trials Award Program Image

    POSTED 

    04-27-22

    Gilead Sciences Announces Support for the Robert A. Winn Diversity in Clinical Trials Award Program

    Read more about the program and its goal of helping enhance the development of therapeutics for all populations.
    Mom Celebrates Sons' Milestones: Julie's CAR T-cell Therapy Journey Image

    POSTED 

    04-21-22

    Mom Celebrates Sons' Milestones: Julie's CAR T-cell Therapy Journey

    Julie and her husband Bob were enjoying being empty nesters and getting ready to head on a beach vacation when Julie started feeling sick. A few weeks before the trip, Julie’s symptoms – a dry cough and shortness of breath – got worse, so she went to an urgent care center near their home in Lower Bu...
    The Translatinx Network Helps a Resilient Community 'Live Its Truth' Image

    POSTED 

    04-19-22

    The Translatinx Network Helps a Resilient Community 'Live Its Truth'

    “In 2005, I began dreaming about starting a trans-led, immigrant-led organization,” she says. “My dream came true two years later when I started the nonprofit.”
    Tour for Diversity in Medicine, Gilead Sciences and the Advisory Group to SHC Vaccine Equity Program to Receive Booker T. Washington Award From National Minority Quality Forum Image

    POSTED 

    04-18-22

    Tour for Diversity in Medicine, Gilead Sciences and the Advisory Group to SHC Vaccine Equity Program to Receive Booker T. Washington Award From National Minority Quality Forum

    The National Minority Quality Forum (NMQF) announced today that it will honor the Tour for Diversity in Medicine, Gilead Sciences and the Advisory Group to SHC Vaccine Equity Program with its highly acclaimed Booker T. Washington Award.
    Four Questions With Anu Osinusi: Gilead's Commitment to People Living With Viral Hepatitis Image

    POSTED 

    04-14-22

    Four Questions With Anu Osinusi: Gilead's Commitment to People Living With Viral Hepatitis

    Anu Osinusi recently spoke with us about how hepatitis research and treatment have changed over her career, why HDV is considered the “forgotten virus” and what’s next for Gilead.
    Gilead Sciences Logo

    Gilead Sciences

    Gilead Sciences

    Join today and get the latest delivered to your inbox